Metformin Zentiva 850 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

metformin zentiva 850 mg tabletti, kalvopäällysteinen

zentiva, k.s. - metformin hydrochloride - tabletti, kalvopäällysteinen - 850 mg - metformiini

Metformin Zentiva 500 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

metformin zentiva 500 mg tabletti, kalvopäällysteinen

zentiva, k.s. - metformin hydrochloride - tabletti, kalvopäällysteinen - 500 mg - metformiini

Zolsketil pegylated liposomal 유럽 연합 - 핀란드어 - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Xofigo 유럽 연합 - 핀란드어 - EMA (European Medicines Agency)

xofigo

bayer ag - radium (223ra) dichloride - prostatiset kasvaimet - terapeuttiset radiofarmaseuttiset valmisteet - xofigo on tarkoitettu aikuisilla, joilla on kastrointuntuvaa eturauhassyöpää, oireeton luumetastaaseja eikä tunnettuja viskeraalisia metastaaseja.

Cisordinol 2 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

cisordinol 2 mg tabletti, kalvopäällysteinen

h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 2 mg - tsuklopentiksoli

Cisordinol 10 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

cisordinol 10 mg tabletti, kalvopäällysteinen

h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 10 mg - tsuklopentiksoli

Cisordinol 25 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

cisordinol 25 mg tabletti, kalvopäällysteinen

h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 25 mg - tsuklopentiksoli

Betaserc 8 mg tabletti 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

betaserc 8 mg tabletti

viatris oy - betahistine dihydrochloride - tabletti - 8 mg - betahistiini

Zyrtec 10 mg tabletti, kalvopäällysteinen 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

zyrtec 10 mg tabletti, kalvopäällysteinen

ucb pharma oy finland - cetirizine dihydrochloride - tabletti, kalvopäällysteinen - 10 mg - setiritsiini

Betaserc 16 mg tabletti 핀란드 - 핀란드어 - Fimea (Suomen lääkevirasto)

betaserc 16 mg tabletti

viatris oy - betahistine dihydrochloride - tabletti - 16 mg - betahistiini